Yet, at first glance retail investors might get excited about the shareholder base… but it is important to look at their cost basis.

Just last year, DNA raised capital at a post-money valuation of approximately $5 billion yet the company is not a materially better company whatsoever.ĭNA only has $40 million of annualized “actual” synthetic biology revenue when you strip out their revenue from COVID testing and revenue from JVs set up by DNA where they invested. The same type of scheme that has made a new generation of investors weary of Wall Street.ĭNA today is valued at $24 billion. Schrödinger has a post-money valuation in the range of 500M to 1B as of May 20, 2019, according to PrivCo. is an American life sciences and materials science company founded in 1990 that develops software for computational chemistry and has a pipeline of collaborative and internal drug discovery programs. Pavilion Capital and Michael Antonov are the most recent investors. Their stock opened with 17.00 in its IPO. Let’s be clear – Ginkgo Bioworks is by no means a scam, rather it is a scheme and a very legal one. Schrödinger is registered under the ticker NASDAQ:SDGR.

We’re sure by now you’ve read Scorpion Capital’s report and understand that Ginkgo Bioworks (DNA) is filled with red flags including: Stock analysis for Schrodinger Inc/United States (SDGR:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. The company is headquartered in New York, New York.Ginkgo Bioworks (DNA) – It’s Not a Scam… It’s a Scheme A stock valuation and forecasting report include rating, fair value assessment, return forecasts, market ratio-based valuations and comparable analysis. In A Glance Schrodinger (SDGR) Stock Performance and Technical Trend Chart. Co.s software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. provides a physics-based software platform that enables the discovery of novel molecules for drug development and material applications. Schrodinger is engaged in developing a physics-based software platform that enables discovery of molecules for drug development and materials applications. MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLCġ20 WEST 45TH STREET, 17TH FLOOR, NEW YORK, NY, US

WELLS FARGO & COMPANY/MN (WFC, WFC-PL, WFC-PN, WFC-PO, WFC-PP, WFC-PQ, WFC-PR, WFC-PT, WFC-PV, WFC-PW, WFC-PX, WFC-PY, WFC-PZ) Get the latest Schrodinger Inc (SDGR) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Schrodinger Inc SDGR:NASDAQ Open51.37 Day High52.65 Day Low50.89 Prev Close52.29 52 Week High117.00 52 Week High Date02/22/21 52 Week Low47.59 52 Week. MORGAN STANLEY (MS, CNY, INR, URR, MLPY, MS-PA, MS-PF, MS-PI, MS-PK, MS-PL)

Sdgr ticker